Guidance UpgradeWELL increased its 2024 revenue guidance, suggesting confidence in continued business growth and cash flow gains.
Strong PerformanceWELL Health reported strong Q423 results with record revenues/EBITDA driven by acquisitions, strong patient visits, and organic growth.
Valuation OpportunityWELL trades at a discount to its US digital health peers, indicating potential for market re-rating and upside for investors.